Viewing Study NCT03786757

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:46 PM
Ignite Modification Date: 2026-02-25 @ 10:04 PM
Study NCT ID: NCT03786757
Status: UNKNOWN
Last Update Posted: 2018-12-26
First Post: 2018-12-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ)
Sponsor: RenJi Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None ST Segment Elevation Myocardial Infarction View
None Left Ventricular Thrombus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None STEMI View
None left ventricular thrombus View
None rivaroxaban View